Cargando…
Cardiac Fibrosis Is Associated With Decreased Circulating Levels of Full-Length CILP in Heart Failure
Cardiac fibrosis is a pathological process associated with various forms of heart failure. This study identified latent transforming growth factor-β binding protein 2, cartilage oligomeric matrix protein, and cartilage intermediate layer protein 1 as potential biomarkers for cardiac fibrosis. All 3...
Autores principales: | Park, Shuin, Ranjbarvaziri, Sara, Zhao, Peng, Ardehali, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251193/ https://www.ncbi.nlm.nih.gov/pubmed/32478206 http://dx.doi.org/10.1016/j.jacbts.2020.01.016 |
Ejemplares similares
-
Circulating Levels of CILP2 Are Elevated in Coronary Heart Disease and Associated with Atherosclerosis
por: Hu, Wenjing, et al.
Publicado: (2020) -
TGF-β Inhibitor CILP as a Novel Biomarker for Cardiac Fibrosis
por: Groß, Sonja, et al.
Publicado: (2020) -
CILP-2 is a novel secreted protein and associated with insulin resistance
por: Wu, Tong, et al.
Publicado: (2019) -
Cartilage intermediate layer protein 1 (CILP1): A novel mediator of cardiac extracellular matrix remodelling
por: van Nieuwenhoven, Frans A., et al.
Publicado: (2017) -
Functional polymorphisms in asporin and CILP together with joint loading predispose to hand osteoarthritis
por: Taipale, Mari, et al.
Publicado: (2017)